Rapid phenotypic drug susceptibility assay for HIV-1 with a CCR5 expressing indicator cell line (Q40893991)

24 September 2017

Rapid phenotypic drug susceptibility assay for HIV-1 with a CCR5 expressing indicator cell line (English)

1 reference

24 September 2017

0 references

Pirounaki M

1

1 reference

24 September 2017

Heyden NA

series ordinal

2

1 reference

24 September 2017

Arens M

series ordinal

3

1 reference

24 September 2017

Ratner L

series ordinal

4

1 reference

24 September 2017

1 March 2000

1 reference

Journal of Virological Methods

24 September 2017

1 reference

24 September 2017

85

1 reference

24 September 2017

151-161

1 reference

24 September 2017

1-2

1 reference

A sensitive reporter cell line for HIV-1 tat activity, HIV-1 inhibitors, and T cell activation effects

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

Cell type-specific fusion cofactors determine human immunodeficiency virus type 1 tropism for T-cell lines versus primary macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

A new classification for HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

Identification of HIV1 determinants for T lymphoid cell line infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

Distinct biological and serological properties of human immunodeficiency viruses from the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

Change in coreceptor use correlates with disease progression in HIV-1--infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

Zidovudine resistance and HIV-1 disease progression during antiretroviral therapy. AIDS Clinical Trials Group Protocol 116B/117 Team and the Virology Committee Resistance Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

Identification of a major co-receptor for primary isolates of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

Size and duration of zidovudine benefit in 1003 HIV-infected patients: US Army, Navy, and Air Force natural history data

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

The role of mononuclear phagocytes in HTLV-III/LAV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

A new reporter cell line to monitor HIV infection and drug susceptibility in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

A novel approach to assessing the drug susceptibility and replication of human immunodeficiency virus type 1 isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

Clinical significance of drug resistance in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

Susceptibilities of zidovudine-susceptible and -resistant human immunodeficiency virus isolates to antiviral agents determined by using a quantitative plaque reduction assay

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

Additional mutations detected in sequential HIV-1 isolates from ZDV-treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

Human immunodeficiency virus type 1 protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

Quantitation of zidovudine-resistant human immunodeficiency virus type 1 in the blood of treated and untreated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

Ordered accumulation of mutations in HIV protease confers resistance to ritonavir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

Pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

HIV treatment failure: testing for HIV resistance in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

Zidovudine susceptibility testing of human immunodeficiency virus type 1 (HIV) clinical isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 isolates from heavily treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

Variations in growth capacity of HIV in peripheral blood mononuclear cell preparations from different individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

HIV-1 subtype and second-receptor use

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900163-9

7 January 2021

10.1016/S0166-0934(99)00163-9

Identifiers

DOI

1 reference

24 September 2017

1 reference